THYROGENONE Trademark

Trademark Overview

On Thursday, September 2, 2004, a trademark application was filed for THYROGENONE with the United States Patent and Trademark Office. The USPTO has given the THYROGENONE trademark a serial number of 78477582. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, February 28, 2016. This trademark is owned by Genzyme Corporation. The THYROGENONE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing health care information pertaining to thyroid disease
thyrogenone

General Information

Serial Number78477582
Word MarkTHYROGENONE
Filing DateThursday, September 2, 2004
Status800 - REGISTERED AND RENEWED
Status DateSunday, February 28, 2016
Registration Number3038483
Registration DateTuesday, January 3, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2005

Trademark Statements

Goods and ServicesProviding health care information pertaining to thyroid disease

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 10, 2004
Primary Code044
First Use Anywhere DateTuesday, September 7, 2004
First Use In Commerce DateTuesday, September 7, 2004

Trademark Owner History

Party NameGenzyme Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 12, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 12, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, February 28, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, February 28, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, February 28, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, February 28, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 14, 2015TEAS SECTION 8 & 9 RECEIVED
Friday, September 23, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, September 22, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 22, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 19, 2011TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 3, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, November 22, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, November 18, 2005ASSIGNED TO LIE
Monday, November 14, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 1, 2005STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 18, 2005USE AMENDMENT FILED
Tuesday, October 18, 2005TEAS STATEMENT OF USE RECEIVED
Tuesday, October 4, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2005PUBLISHED FOR OPPOSITION
Thursday, June 30, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 22, 2005NOTICE OF PUBLICATION
Tuesday, April 5, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 1, 2005ASSIGNED TO LIE
Thursday, March 31, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 31, 2005EXAMINERS AMENDMENT E-MAILED
Thursday, March 31, 2005EXAMINERS AMENDMENT -WRITTEN
Thursday, March 31, 2005ASSIGNED TO EXAMINER
Friday, September 10, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

thyrogenone thyroid disease pertaining information health care providing